Detalles de la búsqueda
1.
Complete Remission with Partial Hematological Recovery as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia.
Blood
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728428
2.
FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
Oncologist
; 27(10): 892-899, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983953
3.
FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.
Oncologist
; 27(6): 493-500, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35363318
4.
Using marginal structural models to analyze the impact of subsequent therapy on the treatment effect in survival data: Simulations and clinical trial examples.
Pharm Stat
; 20(6): 1088-1101, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33908174
5.
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
Oncologist
; 25(2): e328-e334, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043777
6.
FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia.
Oncologist
; 23(11): 1366-1371, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30018129
7.
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.
Oncologist
; 23(12): 1511-1519, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30115735
8.
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome.
Oncologist
; 23(8): 943-947, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29622697
9.
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia.
Oncologist
; 23(9): 1103-1108, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650683
10.
Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated.
Haematologica
; 103(10): 1708-1719, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30076185
11.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.
Biol Blood Marrow Transplant
; 21(8): 1343-59, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25985921
12.
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
Biol Blood Marrow Transplant
; 21(6): 984-99, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25796139
13.
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy.
Clin Cancer Res
; 28(14): 2989-2993, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35325108
14.
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.
Clin Cancer Res
; 28(12): 2488-2492, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135839
15.
FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation.
Clin Cancer Res
; 27(13): 3515-3521, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33632926
16.
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.
Biol Blood Marrow Transplant
; 16(8): 1037-69, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20580849
17.
Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation.
Pediatr Blood Cancer
; 54(2): 291-8, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19743300
18.
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults.
Clin Cancer Res
; 26(2): 328-331, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31444252
19.
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.
Clin Cancer Res
; 26(16): 4280-4288, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32393603
20.
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Clin Cancer Res
; 26(3): 532-536, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31548341